Mar 21, 2023 | Brand Name Drugs, Diabetes, Drug costs, Generic Drugs, Insulin, Kurt Harden, MedBen Rx, MedBen University, Pharmacy Benefits Manager (PBM), Prescription
Earlier this month, drug manufacturer Eli Lilly announced that it cutting the cost of two of its prescription brand insulins, Humalog and Humulin, by 70%, and capping out-of-pocket costs for privately insured patients at $35 a month. Competing drugmakers Novo Nordisk...
Feb 17, 2023 | Affordable Care Act, Birth Control, Compliance, News, Prescription
On February 2, 2023, the Departments of Labor, Health and Human Services, and Treasury (the “Tri-Agencies”) proposed a rule to expand women’s access to birth control under the Affordable Care Act (ACA). The proposed rule revises the exemption allowances...
Feb 3, 2023 | Alternative Reimbursement Strategies, Claims, Cost Savings, Direct-to-Employer Contracting, Drug costs, Forensic claims review, Gene therapy, Health care costs, Inflation, MedBen Rx, MedBen WellLiving, Prescription, Rx Costs, Savings, Specialty Drugs, Wellness
Even though health care costs have not seen the same rate of inflation as other industries, that’s about to change. Fortunately, MedBen has a variety of inflation-hedging solutions to counter rising costs. As a recent Self-Insurer article notes, health care...
Jan 6, 2023 | Drug costs, Drugmakers, News, Prescription, Rx Costs
From Reuters: “Drugmakers including Pfizer Inc, GlaxoSmithKline PLC, Bristol Myers Squibb, AstraZeneca PLC and Sanofi SA plan to raise prices in the United States on more than 350 unique drugs in early January, according to data analyzed by healthcare research...
Dec 27, 2022 | Alternative Reimbursement Strategies, Client Surveys, Kurt Harden, MedBen Rx, Prescription, Reference-Based Pricing, Regulatory
On behalf of our entire team, I wish you a Happy New Year and thank you for your continued business with MedBen. We often say that “MedBen Delivers,” and it’s a statement that covers a variety of factors such as plan design strategies, claims processing accuracy, and...
Dec 22, 2022 | Lobbying, Pharmacy Benefits Manager (PBM), Prescription, Spending
A review of the biggest spenders in health care lobbying by OpenSecrets reveals that, in the leadup to the 2021-22 election cycle, 16 of the top 25 lobbyists were pharmaceutical & health product organizations (see table below). The top health care lobbyist,...
